[go: up one dir, main page]

WO2009153806A2 - Process for preparing memantine hydrochloride substantially free of !mpurities - Google Patents

Process for preparing memantine hydrochloride substantially free of !mpurities Download PDF

Info

Publication number
WO2009153806A2
WO2009153806A2 PCT/IN2009/000274 IN2009000274W WO2009153806A2 WO 2009153806 A2 WO2009153806 A2 WO 2009153806A2 IN 2009000274 W IN2009000274 W IN 2009000274W WO 2009153806 A2 WO2009153806 A2 WO 2009153806A2
Authority
WO
WIPO (PCT)
Prior art keywords
memantine
memantine hydrochloride
solvent
produce
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2009/000274
Other languages
French (fr)
Other versions
WO2009153806A3 (en
Inventor
Pradeep Kumar Jauhari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMACEUTICAL SOLUTIONS FZCO
SAIRAM ORGANICS PVT Ltd
Original Assignee
PHARMACEUTICAL SOLUTIONS FZCO
SAIRAM ORGANICS PVT Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMACEUTICAL SOLUTIONS FZCO, SAIRAM ORGANICS PVT Ltd filed Critical PHARMACEUTICAL SOLUTIONS FZCO
Publication of WO2009153806A2 publication Critical patent/WO2009153806A2/en
Anticipated expiration legal-status Critical
Publication of WO2009153806A3 publication Critical patent/WO2009153806A3/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82Purification; Separation; Stabilisation; Use of additives
    • C07C209/84Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Definitions

  • the present invention relates to a process for the preparation of l-amino-3,5- dimethyladamantane hydrochloride (hereinafter referred to by the officially adopted name "Memantine hydrochloride”), substantially free of impurities.
  • Memantine hydrochloride is chemically known as l-amino-3,5- dimethyladamantane hydrochloride and it is represented by the structural formula 1
  • Memantine hydrochloride is commercially available in the market under the trademark Namenda®.
  • Namenda® is available for oral administration as capsule-shaped, film- coated tablets containing 5 mg and 10 mg of memantine hydrochloride.
  • U.S. Patent No. 3,391,142 discloses the synthesis of memantine hydrochloride and its precursors, l-acetamido-3,5-dimethyl-adamantane, by treating l-bromo-3,5- dimethyl adamantane, with a mixture of acetonitrile and sulphuric acid to give the crude intermediate product in 100 percent yield.
  • the intermediate product is subjected to alkaline hydrolysis with sodium hydroxide in diethylene glycol by refluxing at a temperature of greater than 190°C for six hours.
  • the hydrolyzed product is diluted with water, followed by several benzene extractions, and the memantine free base is recovered by solvent distillation.
  • U.S. Patent No. 4,122,193 & Chinese patent CN 1400207A discloses pharmacological compositions and methods for treating living mammals suffering from hyperkinesias, as well as memantine hydrochloride, hydrobromide, and sulphate synthesis, where in the memantine hydrochloride is prepared by treating l-halo-3,5- dimethyl adamantane with urea at high temperature, and thermally decomposing the resulting urea intermediate.
  • Japanese Patent Publication No. 2002275142 discloses the use of N-hydroxy phthalimide to prepare l-acetamido-3,5-dimethyl adamantane with low yield.
  • CN 1335299 discloses the process of synthesis of memantine hydrochloride
  • l-bromo-3,5-dimethyl adamantane acetonitrile and sulfuric acid are made to produce acetamination reaction, and the product collected in water is made to produce alcoholysis reaction with sodium other and polyalcohol containing no ether linkage.
  • Memantine is then obtained through chloroform extraction and is finally acidified with hydrochloric acid and chloroform recrystallized to obtain memantine hydrochloride.
  • the said process employs the use of harsh basic conditions in the hydrolysis step.
  • CN 1488622 discloses the process of preparing memantine hydrochloride by treating 1, 3 -dimethyl adamantine with t-butyl-chloride & AlCl 3 to prepare 1-chloro- 3,5-dimethyl adamantane which is then amidated with acetamide and subjected to basic hydrolysis in the presence of sodium hydroxide in ethanediol or glycerin solvent to provide memantine base which is then subjected to dry HCl gas to obtain crude Memantine hydrochloride which is further purified by recrystallization.
  • W02005023753 discloses the process of preparing memantine hydrochloride by using bromine to get the bromo derivative (l-bromo-3,5 dimethyladamantane) which is then reacted with urea / HCOOH to give 1-acetamido analogue & then hydrolysis & acidification with HCl to obtain memantine hydrochloride.
  • the deficiencies of the prior art include harsh reaction condition, undesirable by products such as bromine, very high temperatures, the need for high pressures, and the use of dangerous reactants.
  • An aspect of the invention includes a process for preparing memantine hydrochloride starting from 1,3 -dimethyl adamantane and there by eliminating the impurities arising out from l-halo-3,5-dimethyl-adamantane.
  • hydrolysis of l-acetamido-3,5-dimethyl adamantane step is directed to synthesize 1- amino-3,5-dimethyl adamantane in very shorter duration of time with more purity and as such high temperature, degradation impurities that may arise due to longer time, are minimized.
  • the Memantine HCl salt is obtained by using eco-friendly solvents.
  • Memantine hydrochloride is then subjected to purification process to further eliminate any undesired impurity to give desired product in better quality and purity.
  • Another aspect of the invention includes a process for preparing memantine hydrochloride that avoids the halo intermediates which are obtained by corrosive processes.
  • a process for the preparation of memantine hydrochloride which comprises a) reacting 1,3-dimethyladamantane with acetontitrile and sulphuric acid to produce l-acetamido-3,5-dimethyl adamantane; b) reacting l-acetamido-3,5-dimethyl adamantane with base in the presence of solvent to produce memantine; c) reacting memantine with alcoholic HCl in the presence of solvents to produce memantine hydrochloride; d) purification of memantine hydrochloride using aliphatic solvents.
  • the present invention provides a process for the preparation of memantine hydrochloride, which involves, reacting 1,3-dimethyladamantane with acetontitrile and sulphuric acid catalyzed by long chain carbinol in a solvent like chlorinated solvent at about 50 to 80 0 C, for about 2-5 hours to from l-acetamido-3,5- dimethyladamantane.
  • Carbinol used in the reaction may be selected from isopropyl alcohol, butanol, isoamyl alcohol and tertiary butyl alcohol.
  • l-acetamido-3,5-dimethyladamantane is deacetylated by subjecting it to basic hydrolysis in the presence of solvent at about 150 to 18O 0 C, for about 2-3 hours to from memantine base.
  • the bases used in the hydrolysis step are selected from potassium hydroxide, Sodium hydroxide, lithium hydroxide, and carbonates such as Barium carbonate and Cesium carbonate.
  • the molar ratio of base can be varying from 2-10 moles per mole.
  • the deacetylation of acetamido compound is carried out in a solvent selected from the group of polyethylene glycols H(OCH2- CH2)n OH where is greater than 4, monoethylene glycol, diethylene glycol along with chlorinated solvents such as dichloromethane, dichloroethane, carbon tetrachloride and chloroform.
  • a solvent selected from the group of polyethylene glycols H(OCH2- CH2)n OH where is greater than 4, monoethylene glycol, diethylene glycol along with chlorinated solvents such as dichloromethane, dichloroethane, carbon tetrachloride and chloroform.
  • Memantine free base obtained is dissolved in ketonic solvents such as MIBK, cyclohexanone, cyclopentanone or acetone and then alcoholic HCl is added to adjust the pH of the solution to 2-4.
  • the reaction mixture is then cooled preferably to a temperature of about O 0 C to room temperature to obtain crude memantine hydrochloride.
  • the present further provides a process for purification of memantine hydrochloride which comprises of treating memantine hydrochloride with aliphatic solvents selected from hexane, cyclopentane, & cyclohexane at 30°- 80°c preferably between 45-50°c and time between 2 to 20 hrs, preferably 6-8 hrs.
  • the reaction mass is filtered and washed with the solvent (2-5 times of the material taken).
  • the filtered mass is dried to a constant wt. that gives GC purity more than 99.6%.
  • a mixture of 1,3-dimethyl adamantane, acetonitrile and t-butanol heat to 50 to 80 0 C and add cone, sulphuric acid slowly within 3 hours. Maintain at 70 - 80°C for 3 hours.
  • the reaction mixture product was poured in to ice and extracted with dichloromethane and wash the dichloromethane layer with water and sodium bicarbonate solution. Wash with water and dry with sodium sulphate. Distilled the dichloromethane and concentrated of organic layer and add n-Hexane and reflux. Cool to 0°C and filter the compound and wash with chilled n-Hexane and dry the compound l-Acetamido-3,5-dimethyl adamantane.
  • Memantine free base obtained is dissolved in acetone and then alcoholic HCl is added to adjust the pH of the solution to 2-4. The reaction mixture is then cooled preferably to a temperature of about O 0 C to room temperature to obtain crude memantine hydrochloride.
  • Impure Memantine HCl is taken and to cyclohexane is added and the reaction is heated at a temp., ranging from 45-5OfC and time between 6-8 hrs.
  • the reaction mass is filtered and washed with the solvent (2-5 times of the material taken).
  • the filtered mass is dried to a constant wt. that gives GC purity more than 99.6%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for preparing memantine hydrochloride free from impurities comprises (a) reacting 1,3-dimethyladamantane with acetonitrile and sulphuric acid to produce 1 - acetamido-3,5- dimethyl adamantane; (b) treating 1-acetamido-3,5-dimethyl adamantane with base in the presence of solvent to produce memantine; (c) reacting memantine with alcoholic HCI in the presence of solvents to produce memantine hydrochloride; and purification of memantine hydrochloride using aliphatic solvents.

Description

PROCESS FOR PREPARING MEMANTINE HYDROCHLORIDE SUBSTANTIALLY FREE OF IMPURITIES
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of Indian Provisional Patent Application No. 1143/CHE/2008, filed on May 9, 2008.
FIELD OF THE INVENTION
The present invention relates to a process for the preparation of l-amino-3,5- dimethyladamantane hydrochloride (hereinafter referred to by the officially adopted name "Memantine hydrochloride"), substantially free of impurities.
BACKGROUND OF THE INVENTION
Memantine hydrochloride is chemically known as l-amino-3,5- dimethyladamantane hydrochloride and it is represented by the structural formula 1
Figure imgf000002_0001
Formula 1
It belongs to the group of tricyclic antiviral drugs (TAV). It provides persistent activation of N-methyl-D-aspartate (NMDA) receptors, and thus, can be used in the treatment of Parkinson's disease and Alzheimer's disease. Memantine hydrochloride is commercially available in the market under the trademark Namenda®. Namenda® is available for oral administration as capsule-shaped, film- coated tablets containing 5 mg and 10 mg of memantine hydrochloride.
Different strategies for the preparation of Memantine hydrochloride are disclosed in the prior art:
U.S. Patent No. 3,391,142 discloses the synthesis of memantine hydrochloride and its precursors, l-acetamido-3,5-dimethyl-adamantane, by treating l-bromo-3,5- dimethyl adamantane, with a mixture of acetonitrile and sulphuric acid to give the crude intermediate product in 100 percent yield. The intermediate product is subjected to alkaline hydrolysis with sodium hydroxide in diethylene glycol by refluxing at a temperature of greater than 190°C for six hours. The hydrolyzed product is diluted with water, followed by several benzene extractions, and the memantine free base is recovered by solvent distillation. The free base is then diluted with ether, and the addition of hydrogen chloride gas provides crude memantine hydrochloride. Crystallization of the hydrochloride from an ethanol of ethanol and ether gives pure memantine hydrochloride in 69.8 %yield.
U.S. Patent No. 4,122,193 & Chinese patent CN 1400207A, discloses pharmacological compositions and methods for treating living mammals suffering from hyperkinesias, as well as memantine hydrochloride, hydrobromide, and sulphate synthesis, where in the memantine hydrochloride is prepared by treating l-halo-3,5- dimethyl adamantane with urea at high temperature, and thermally decomposing the resulting urea intermediate.
U.S. Patent No. 5,599,998 exhibited electrophilic substitution on metallated 3,5-dimethyl-adamantane by chloramine. Czech Patent No. 282398B6 discloses the synthesis of memantine hydrochloride by basic hydrolysis of l-acetamido-3,5-dimethyl adamantane at high pressure.
Japanese Patent Publication No. 2002275142 discloses the use of N-hydroxy phthalimide to prepare l-acetamido-3,5-dimethyl adamantane with low yield.
CN 1335299 discloses the process of synthesis of memantine hydrochloride In the said process l-bromo-3,5-dimethyl adamantane, acetonitrile and sulfuric acid are made to produce acetamination reaction, and the product collected in water is made to produce alcoholysis reaction with sodium other and polyalcohol containing no ether linkage. Memantine is then obtained through chloroform extraction and is finally acidified with hydrochloric acid and chloroform recrystallized to obtain memantine hydrochloride. The said process employs the use of harsh basic conditions in the hydrolysis step.
CN 1488622 discloses the process of preparing memantine hydrochloride by treating 1, 3 -dimethyl adamantine with t-butyl-chloride & AlCl3 to prepare 1-chloro- 3,5-dimethyl adamantane which is then amidated with acetamide and subjected to basic hydrolysis in the presence of sodium hydroxide in ethanediol or glycerin solvent to provide memantine base which is then subjected to dry HCl gas to obtain crude Memantine hydrochloride which is further purified by recrystallization.
W02005023753 discloses the process of preparing memantine hydrochloride by using bromine to get the bromo derivative (l-bromo-3,5 dimethyladamantane) which is then reacted with urea / HCOOH to give 1-acetamido analogue & then hydrolysis & acidification with HCl to obtain memantine hydrochloride. The deficiencies of the prior art include harsh reaction condition, undesirable by products such as bromine, very high temperatures, the need for high pressures, and the use of dangerous reactants.
Hence, there is a need for an improved process for preparing memantine hydrochloride that can take care of prior art deficiencies, improvement in yields, replacement of solvents like ether and reaction kinetics.
SUMMARY OF THE INVENTION
An aspect of the invention includes a process for preparing memantine hydrochloride starting from 1,3 -dimethyl adamantane and there by eliminating the impurities arising out from l-halo-3,5-dimethyl-adamantane. In another aspect hydrolysis of l-acetamido-3,5-dimethyl adamantane step is directed to synthesize 1- amino-3,5-dimethyl adamantane in very shorter duration of time with more purity and as such high temperature, degradation impurities that may arise due to longer time, are minimized. Further in another aspect, the Memantine HCl salt is obtained by using eco-friendly solvents. Memantine hydrochloride is then subjected to purification process to further eliminate any undesired impurity to give desired product in better quality and purity.
Another aspect of the invention includes a process for preparing memantine hydrochloride that avoids the halo intermediates which are obtained by corrosive processes.
DETAILED DESCRIPTION OF THE INVENTION
According to the present invention there is provided a process for the preparation of memantine hydrochloride which comprises a) reacting 1,3-dimethyladamantane with acetontitrile and sulphuric acid to produce l-acetamido-3,5-dimethyl adamantane; b) reacting l-acetamido-3,5-dimethyl adamantane with base in the presence of solvent to produce memantine; c) reacting memantine with alcoholic HCl in the presence of solvents to produce memantine hydrochloride; d) purification of memantine hydrochloride using aliphatic solvents.
In one embodiment, the present invention provides a process for the preparation of memantine hydrochloride, which involves, reacting 1,3-dimethyladamantane with acetontitrile and sulphuric acid catalyzed by long chain carbinol in a solvent like chlorinated solvent at about 50 to 800C, for about 2-5 hours to from l-acetamido-3,5- dimethyladamantane. Carbinol used in the reaction may be selected from isopropyl alcohol, butanol, isoamyl alcohol and tertiary butyl alcohol.
Further in another aspect l-acetamido-3,5-dimethyladamantane is deacetylated by subjecting it to basic hydrolysis in the presence of solvent at about 150 to 18O0C, for about 2-3 hours to from memantine base. The bases used in the hydrolysis step are selected from potassium hydroxide, Sodium hydroxide, lithium hydroxide, and carbonates such as Barium carbonate and Cesium carbonate. The molar ratio of base can be varying from 2-10 moles per mole. The deacetylation of acetamido compound is carried out in a solvent selected from the group of polyethylene glycols H(OCH2- CH2)n OH where is greater than 4, monoethylene glycol, diethylene glycol along with chlorinated solvents such as dichloromethane, dichloroethane, carbon tetrachloride and chloroform.
Memantine free base obtained is dissolved in ketonic solvents such as MIBK, cyclohexanone, cyclopentanone or acetone and then alcoholic HCl is added to adjust the pH of the solution to 2-4. The reaction mixture is then cooled preferably to a temperature of about O0C to room temperature to obtain crude memantine hydrochloride.
The present further provides a process for purification of memantine hydrochloride which comprises of treating memantine hydrochloride with aliphatic solvents selected from hexane, cyclopentane, & cyclohexane at 30°- 80°c preferably between 45-50°c and time between 2 to 20 hrs, preferably 6-8 hrs. The reaction mass is filtered and washed with the solvent (2-5 times of the material taken). The filtered mass is dried to a constant wt. that gives GC purity more than 99.6%.
The present invention will now be described in more detail by the way of examples which should not construed as limiting the invention thereto The following examples, which include preferred embodiments, will serve to illustrate the practice of this invention, it being understood that the particulars shown are by way of example and for purpose of illustrative discussion of preferred embodiments of the invention.
Examples
Example 1
Preparation of l-Acetamido-3,5-dimethyl adamantane
A mixture of 1,3-dimethyl adamantane, acetonitrile and t-butanol heat to 50 to 800C and add cone, sulphuric acid slowly within 3 hours. Maintain at 70 - 80°C for 3 hours. The reaction mixture product was poured in to ice and extracted with dichloromethane and wash the dichloromethane layer with water and sodium bicarbonate solution. Wash with water and dry with sodium sulphate. Distilled the dichloromethane and concentrated of organic layer and add n-Hexane and reflux. Cool to 0°C and filter the compound and wash with chilled n-Hexane and dry the compound l-Acetamido-3,5-dimethyl adamantane.
Example 2
Preparation of Memantine base
A mixture of l-acetamido-3,5-dimethyl adamantane, sodium hydroxide in Poly ethylene glycol-400 was heated to 170 -18O0C and maintain for a period of 2-3 hours. The reaction product mixture was cooled to RT and poured water thus obtained was extracted 3 times with 10 ml portion of dichloromethane. Distill dichloromethane completely; to obtained memantine base. Product is obtained in 90% yield.
Example 3
Preparation of Memantine Hydrochloride
Memantine free base obtained is dissolved in acetone and then alcoholic HCl is added to adjust the pH of the solution to 2-4. The reaction mixture is then cooled preferably to a temperature of about O0C to room temperature to obtain crude memantine hydrochloride.
Example 4
Purification of Memantine Hydrochloride
Impure Memantine HCl is taken and to cyclohexane is added and the reaction is heated at a temp., ranging from 45-5OfC and time between 6-8 hrs. The reaction mass is filtered and washed with the solvent (2-5 times of the material taken). The filtered mass is dried to a constant wt. that gives GC purity more than 99.6%. It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the scope or spirit of the invention. Other embodiments of the invention will be apparent to those skilled in the art from consideration of specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only with a true scope and spirit of the invention being indicated by the following claims.

Claims

We Claim:
1. A process for preparing memantine hydrochloride comprising the steps of :
e) reacting 1,3-dimethyladamantane with acetontitrile and sulphuric acid to produce l-acetamido-3,5-dimethyl adamantane; f) reacting l-acetarnido-3,5-dimethyl adamantane with base in the presence of solvent to produce memantine; g) reacting memantine with alcoholic HCl in the presence of solvents to produce memantine hydrochloride; h) purification of memantine hydrochloride using aliphatic solvents.
2. A process as claimed in claim 1, wherein the said base in step (b) is selected from the group comprising of potassium hydroxide, Sodium hydroxide, lithium hydroxide, and carbonates such as Barium carbonate and Cesium carbonate
3. A process as claimed in claim 1, wherein the said solvent in step (b) is selected from the group of polyethylene glycols, monoethylene glycol, diethylene glycol dichloromethane, dichloroethane, carbon tetrachloride and chloroform.
4. A process as claimed in claim 1, where in the said alcohol in step (c) is selected from the group comprising of methanol, ethanol, isopropanol or butanol.
5. A process as claimed in claim 1, where in the said solvent in step (c) is selected from the group comprising of MIBK, cyclohexanone, cyclopentanone or acetone.
6. A process as claimed in claim 1, where in the said aliphatic solvent in step (d) is selected from the group comprising of hexane, cyclopentane or cyclohexane.
PCT/IN2009/000274 2008-05-09 2009-05-08 Process for preparing memantine hydrochloride substantially free of !mpurities Ceased WO2009153806A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1143CH2008 2008-05-09
IN1143/CHE/2008 2008-05-09

Publications (2)

Publication Number Publication Date
WO2009153806A2 true WO2009153806A2 (en) 2009-12-23
WO2009153806A3 WO2009153806A3 (en) 2010-12-23

Family

ID=41434514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000274 Ceased WO2009153806A2 (en) 2008-05-09 2009-05-08 Process for preparing memantine hydrochloride substantially free of !mpurities

Country Status (1)

Country Link
WO (1) WO2009153806A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102531919A (en) * 2011-11-09 2012-07-04 广东肇庆星湖生物科技股份有限公司 Preparation method of memantinehydrochloride
CN106946713A (en) * 2017-03-13 2017-07-14 张家港九力新材料科技有限公司 A kind of preparation method of memantine
CN111233670A (en) * 2020-03-09 2020-06-05 四川尚锐生物医药有限公司 Memantine hydrochloride impurity compound and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009057140A2 (en) * 2007-10-30 2009-05-07 Msn Laboratories Limited Improved process for memantine hydrochloride

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102531919A (en) * 2011-11-09 2012-07-04 广东肇庆星湖生物科技股份有限公司 Preparation method of memantinehydrochloride
CN106946713A (en) * 2017-03-13 2017-07-14 张家港九力新材料科技有限公司 A kind of preparation method of memantine
CN111233670A (en) * 2020-03-09 2020-06-05 四川尚锐生物医药有限公司 Memantine hydrochloride impurity compound and preparation method thereof

Also Published As

Publication number Publication date
WO2009153806A3 (en) 2010-12-23

Similar Documents

Publication Publication Date Title
AU2007218140B2 (en) Process for the preparation of adamantanamines
WO2008062472A2 (en) Process for the preparation of memantine
RU2455281C2 (en) Method of producing 1-formamido-3,5-dimethyladamantane
WO2009057140A2 (en) Improved process for memantine hydrochloride
WO2009153806A2 (en) Process for preparing memantine hydrochloride substantially free of !mpurities
WO2005023753A1 (en) A method of preparing memantine hydrochloride
CA2744468A1 (en) An improved process for the preparation of 1-bromo-3,5-dimethyl adamantane
JP4031203B2 (en) (1R, 2S, 4R)-(−)-2-[(2 ′-{N, N-dimethylamino} -ethoxy)]-2- [phenyl] -1,7,7-tri- [methyl]- Process for producing bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
NZ526370A (en) A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
AU2002229575A1 (en) A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
CN104876806A (en) Novel method for synthesizing bisoprolol importance intermediate
CN101412678B (en) Method for synthesizing memantine hydrochloride
HU226690B1 (en) Process for producing fluoxetin
EP2882291A1 (en) An improved process for the preparation of memantine hydrochloride
EP2555616A1 (en) Process for the preparation of memantine hydrochloride
AU2009356855A1 (en) Process for the preparation of Ropinirole and salts thereof
JP2015166383A (en) Method of preparing neramexane or salt thereof
CN112062666A (en) Production process of 6-hydroxycaproic acid
EP1951657A1 (en) Process for the manufacture of iohexol
JP4260941B2 (en) Azetidine-3-ol
CA2930089C (en) Fingolimod hydrochloride process
CA3108358C (en) Preparation method for (1r,3s)-3-amino-1-cyclopentanol and salts thereof
CN113372235B (en) Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acids
CN102234238B (en) Method for preparing 2-(7-methoxy-1-naphthyl) ethylamine industrially
WO2010007351A1 (en) Process for the preparation of memantine and its salts and intermediate for use therein

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09766336

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09766336

Country of ref document: EP

Kind code of ref document: A2